The medical and surgical aesthetics market continues to prosper despite geopolitical and economic challenges. According to data analysed by IMCAS in collaboration with Boston Consulting Group (BCG)1 , the market is expected to grow by 7% a year between 2024 and 2029, growing from a €21.7 billion market to €30.2 billion.

This review examines the major classes of facial injectable fillers, including a novel collagen-based product, a hybrid cooperative hyaluronan, cross-linked hyaluronic acid gels, poly-L-lactic acid, and calcium hydroxylapatite.

Curious about the causes and solutions for botulinum toxin resistance in aesthetic treatments? Discover insights in our latest article.